Elderly patients with undiagnosed or untreated obstructive sleep apnea (OSA) face a particularly heavy economic burden due to comorbidities, according to MD Magazine. A research team at the University of Maryland studied the impact of untreated OSA on the use and cost of health care in a nationally representative sample of Medicare recipients.

Read more »

Experimental standard immunotherapy, which combines a targeted antibody and chemotherapy, can lead to potentially long-term reactions in patients with multiple myeloma who have relapsed or are resistant to other standard treatments, according to the DREAMM-2 study published in the Lancet Oncology.

Read more »

The holidays and winter are approaching, and although this season is celebrated with joy, it can also be incredibly busy and stressful. Did you know that about 40% of people will continue to work despite the fact that they do not feel better? Take care of yourself by providing your body with nutrients that support overall health, your immune system, mood and energy metabolism. Some Vitamins and Supplements are recommended in their category allow to take control of your own health during this season.

Read more »

Influenza is a disease that has historically had serious problems with prevention and treatment. Currently, the flu vaccine is the only vaccine that requires annual administration. This is due to the inherent characteristics of the influenza virus, which exhibits strong antigenic drift and constantly mutates. The virus may look different every year, leaving patients no longer protected. Subsequently, influenza can have a serious health burden; for example, in the United States, there were 810,000 hospital admissions and 61,000 deaths from influenza during the 2017-2018 flu season.

Read more »

FDA representatives have approved lumateperone intracellular therapy (Caplyta) for the treatment of adult schizophrenia, according to the company. It is expected that the drug will be launched in 2020.

Read more »